International Journal of Clinical Oncology

Papers
(The H4-Index of International Journal of Clinical Oncology is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment109
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer64
Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 205050
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)47
Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015  Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis46
Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis45
A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma38
The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study36
Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study32
Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan29
Aging, cancer, and antitumor immunity28
Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis27
Focal therapy with high-intensity focused ultrasound for the localized prostate cancer for Asian based on the localization with MRI-TRUS fusion image-guided transperineal biopsy and 12-cores transperi27
Key promoters of tumor hallmarks25
Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis24
The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan24
Medical guidelines for Li–Fraumeni syndrome 2019, version 1.124
Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy24
Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma24
Salivary metabolites to detect patients with cancer: a systematic review23
The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy23
Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma23
Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapy22
0.038150072097778